It's more than a result.
It's a person.

We're Driven To Know.

genetics-icon
Genetics

Innovative solutions that empower researchers, from ALS to fragile X syndrome.

Learn more about our Genetics portfolio
oncology-icon
Oncology

Solving complex molecular challenges, from leukemia to solid tumors.

Learn more about our Oncology portfolio
cdx-icon
Custom & Companion Diagnostics

One partner from clinical concept to product commercialization.

Learn more about partnering with us.
Spotlight

Go Deep with the first and only FDA cleared BCR-ABL1 assay

We are pleased to announce that we have received FDA clearance through the de novo 510(k) process for our QuantideX qPCR BCR-ABL IS Kit for monitoring molecular response in Chronic Myeloid Leukemia patients.

Learn More
Spotlight

Accurate C9orf72 Analysis Just Got Easier!

Introducing AmplideX® PCR/CE C9orf72 Kit (RUO) for high-resolution genotyping of GC-rich hexanucleotide repeat expansions in the C9orf72 gene that are associated with ALS and FTD.

Learn More
Spotlight

NGS RNA Lung Cancer Kit - Coming Soon!

We are pleased to introduce our next NGS solution within the QuantideX® oncology line of assays – QuantideX® NGS RNA Lung Cancer Kit (RUO).

Learn More

The Latest from Asuragen

Introducing the first and only FDA cleared BCR-ABL1 assay

We are pleased to announce that we have received FDA clearance through the de novo 510(k) process for our QuantideX qPCR BCR-ABL IS Kit for monitoring molecular response in Chronic Myeloid Leukemia patients.

Back To
Top

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close